Pharming Group Correlations

PHAR Stock

USD 9.36 0.62 7.09%

The current 90-days correlation between Pharming Group NV and Eliem Therapeutics is 0.03 (i.e., Significant diversification). The correlation of Pharming Group is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Pharming Group Correlation With Market

Good diversification

The correlation between Pharming Group NV and DJI is -0.19 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Pharming Group NV and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharming Group NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Moving together with Pharming Stock

0.75	GNFT	Genfit	Pair Corr
0.67	IMAB	I Mab	Pair Corr
0.61	LPCN	Lipocine	Pair Corr
0.68	ALVO	Alvotech	Pair Corr

Moving against Pharming Stock

0.51	DYAI	Dyadic International	Pair Corr
0.39	PTN	Palatin Technologies	Pair Corr
0.43	INKT	Mink Therapeutics	Pair Corr
0.33	MNMD	Mind Medicine	Pair Corr
0.44	TOVX	Theriva Biologics	Pair Corr

Related Correlations Analysis

	GLSH	ELYM	GNTA	OPT	PRDS	MLYS	ANEB	JANX	RZLT
GLSH		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	GLSH
ELYM	0.0		-0.65	0.02	-0.18	-0.48	0.79	-0.4	-0.29	ELYM
GNTA	0.0	-0.65		0.49	0.16	0.67	-0.45	0.3	0.09	GNTA
OPT	0.0	0.02	0.49		0.1	0.68	0.3	0.01	-0.11	OPT
PRDS	0.0	-0.18	0.16	0.1		0.07	-0.11	0.67	-0.14	PRDS
MLYS	0.0	-0.48	0.67	0.68	0.07		-0.18	0.26	0.34	MLYS
ANEB	0.0	0.79	-0.45	0.3	-0.11	-0.18		-0.25	-0.16	ANEB
JANX	0.0	-0.4	0.3	0.01	0.67	0.26	-0.25		0.43	JANX
RZLT	0.0	-0.29	0.09	-0.11	-0.14	0.34	-0.16	0.43		RZLT
	GLSH	ELYM	GNTA	OPT	PRDS	MLYS	ANEB	JANX	RZLT

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ANEB	+ 0.79	ELYM
MLYS	+ 0.68	OPT
MLYS	+ 0.67	GNTA
JANX	+ 0.67	PRDS
OPT	+ 0.49	GNTA
RZLT	+ 0.43	JANX

High negative correlations

GNTA	- 0.65	ELYM
MLYS	- 0.48	ELYM
ANEB	- 0.45	GNTA
JANX	- 0.4	ELYM
RZLT	- 0.29	ELYM
JANX	- 0.25	ANEB

Risk-Adjusted Indicators

There is a big difference between Pharming Stock performing well and Pharming Group Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Pharming Group's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
GLSH	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ELYM	3.62	(1.16)	0.00	(1.74)	0.00	0.00	6.00	(9.35)	22.16
GNTA	4.36	0.45	0.08	0.74	4.72	(5.86)	12.20	(8.83)	39.54
OPT	2.99	0.21	0.04	0.39	3.83	(3.38)	9.15	(7.49)	24.20
PRDS	1.70	0.40	0.12	(2.03)	1.66	(2.32)	4.28	(2.59)	15.31
MLYS	2.77	0.00	0.03	0.11	3.28	(2.91)	7.51	(5.67)	20.98
ANEB	4.89	(0.04)	(0.01)	0.07	7.29	(5.63)	8.61	(11.48)	76.00
JANX	3.59	0.76	0.22	2.34	2.75	(4.97)	8.19	(5.02)	54.12
RZLT	2.51	(0.14)	0.00	(0.11)	0.00	0.00	5.54	(5.36)	16.12

Pharming Group Corporate Management

Bruno Giannetti	Consultant	Profile
Susanne Embleton	Investor Manager	Profile
Jeroen Wakkerman	Chief Officer	Profile
Stephen Toor	Chief Americas	Profile
MBA MD	CEO Pres	Profile
Daniela Hanovana	Chief Officer	Profile
Ines Bernal	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC